Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Cohort Study of Renal and Bone Outcome After Changing Tenofovir in Patients With Renal Toxicity According to Antiretroviral Strategy

NCT02209740 is registered in ClinicalTrials.gov with Asociacion para el Estudio de las Enfermedades Infecciosas as lead sponsor.

NCT NCT02209740
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02209740 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Cohort Study of Renal and Bone Outcome After Changing Tenofovir in Patients With Renal Toxicity According to Antiretroviral Strategy
Lead sponsor
Asociacion para el Estudio de las Enfermedades Infecciosas
Phase
Observational
Overall status
Completed
Start date
July 31, 2014
Completion date
December 31, 2015
Enrollment
245 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

renal disease